Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 164

Sort by

Sort Order Select

Journal Articles

Defibrotide Reduces Hypercoagulable State in Patients with Sickle Cell Disease-Related Acute Chest Syndrome (IND 127812)

Edo Schaefer, Morgan Anderson-Crannage, Yiouli Panayiota Ktena, Jessica Hochberg, Temima Kanarfogel, John Herrick, Emily Thatcher, Qiuhu Shi, Bruno Hochberg, Yaya Chu, Sankaran Krishnan, Erin Morris, Sandra Fabricatore, John DuFresne, Kenneth R. Cooke, Mitchell S. Cairo

Blood (2024) 144 (Supplement 1): 2515.

https://doi.org/10.1182/blood-2024-205971

Published: 2024

Journal Articles

Fertility and Sexual Development Outcomes in Pubertal and Post-Pubertal Children and Young Adults after Myeloablative Conditioning (MAC) and Familial Haploidentical T-Cell Depleted Allogeneic Stem Cell Transplantation

Hanif Mouehla, Maya Siegel, Edo Schaefer, Julie-An Talano, Shalini Shenoy, Theodore B. Moore, Jordan Milner, Christine Duncan, Anne Panarella, Lauren Harrison, Erin Morris, Mitchell S. Cairo

Blood (2024) 144 (Supplement 1): 7393.

https://doi.org/10.1182/blood-2024-208814

Published: 2024

Journal Articles

A Phase II Study to Evaluate the Safety and Efficacy of Defibrotide and Changes in Plasma Biomarkers in Sickle Cell Disease-Related Acute Chest Syndrome (IND 127812)

Edo Schaefer, Morgan Anderson-Crannage, Jessica Hochberg, Temima Kanarfogel, Yiouli Panayiota Ktena, John Herrick, Emily Thatcher, Qiuhu Shi, Bruno Hochberg, Yaya Chu, Sankaran Krishnan, Erin Morris, Sandra Fabricatore, John DuFresne, Kenneth R. Cooke, Mitchell S. Cairo

Blood (2023) 142 (Supplement 1): 2520.

https://doi.org/10.1182/blood-2023-180804

Published: 2023

Journal Articles

A Phase II Study to Evaluate the Safety and Efficacy of Defibrotide in Children with High Risk Kawasaki Disease (IND 127812)

Edo Schaefer, Qiuhu Shi, Karen Brandstaedter, Kristina Melchert, Darshan Patel, Erin Morris, Sandra Fabricatore, Elizabeth Mintzer, John DuFresne, Kenneth R. Cooke, Mitchell S. Cairo

Blood (2023) 142 (Supplement 1): 5412.

https://doi.org/10.1182/blood-2023-184832

Published: 2023

Journal Articles

Optimizing Ex-Vivo Expanded NK Cell- Mediated Cellular Cytotoxicity By Obinutuzumab Combined with NKTR-255 in Burkitt Lymphoma (BL)

Yaya Chu, Keira Foley, Meijuan Tian, Kayleigh Klose, Jessica Ayala-Cuesta, Dean Anthony Lee, Mario Marcondes, Christian Klein, Mitchell S. Cairo

Blood (2023) 142 (Supplement 1): 2063.

https://doi.org/10.1182/blood-2023-181996

Published: 2023

Journal Articles

Multicenter Pilot Trial of Intrathecal Liposomal Cytarabine Combined with FAB Chemoimmunotherapy with Reduced Doxorubicin in CAYA with Mature De-Novo B-NHL

Anthony N. Audino, Stanton Goldman, Matthew J. Barth, Jessica Hochberg, Ana C. Xavier, Bruce Shiramizu, Qiuhu Shi, Lauren Harrison, Jackie Basso, Javier Oesterheld, Kenneth Matthew Heym, Richard A. Drachtman, Paul Harker-Murray, Sherrie L. Perkins, Rodney R. Miles, Mitchell S. Cairo

Blood (2023) 142 (Supplement 1): 1727.

https://doi.org/10.1182/blood-2023-181756

Published: 2023

Journal Articles

Targeted Immunotherapy and Checkpoint Blockade in Children, Adolescents, and Young Adults with Lymphoma: Radical Hodgkin Cohort

Kayleigh Klose, Jessica Hochberg, Jaclyn Basso, Ana C. Xavier, Matthew J. Barth, Rodney R. Miles, Samir Kahwash, Stephan D. Voss, Suzanne Braniecki, Chitti Moorthy, Saro Armenian, Matthew J. Ehrhardt, Megan Lim, Lauren Harrison, Arvind Budhram, Ariel Stonberg, Stanton Goldman, Mitchell S. Cairo

Blood (2023) 142 (Supplement 1): 3083.

https://doi.org/10.1182/blood-2023-186691

Published: 2023

Journal Articles

Treatment of Refractory Adenovirus (ADV) Infections Using Adv-Specific Cytotoxic T-Lymphocytes (CTLs) in Children, Adolescents and Young Adults (CAYA) Post Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT), Solid Organ Transplantation (SOT), or with Primary Immunodeficiency (PID)

Blood (2023) 142 (Supplement 1): 4836.

https://doi.org/10.1182/blood-2023-188013

Published: 2023

Journal Articles

EBV: the virus that keeps on giving!

Mitchell S. Cairo

Blood (2023) 141 (7): 689–691.

https://doi.org/10.1182/blood.2022018748

Published: 2023

Journal Articles

KIR-favorable TCR-αβ/CD19-depleted haploidentical HCT in children with ALL/AML/MDS: primary analysis of the PTCTC ONC1401 trial

Michael A. Pulsipher, Kwang W. Ahn, Nancy J. Bunin, Nahal Lalefar, Eric Anderson, Allyson Flower, Mitchell S. Cairo, Julie-An Talano, Sonali Chaudhury, Carrie L. Kitko, Jamie L. Duke, Dimitrios Monos, Wing Leung, Christopher C. Dvorak, Hisham Abdel-Azim

Blood (2022) 140 (24): 2556–2572.

https://doi.org/10.1182/blood.2022015959

Published: 2022

Includes: Supplemental data

Journal Articles

Pilot Study Using Induction Chemo-Immunotherapy Followed By Consolidation with Reduced Toxicity Conditioning and Allogeneic Stem Cell Transplant in Advanced Stage Mature Non-Anaplastic T- or NK-Cell Lymphoma/Leukemia in Children, Adolescent, and Young Adults

Ana C. Xavier, Lauren Harrison, Rodney R. Miles, Stephan Voss, Megan S. Lim, Mitchell S. Cairo

Blood (2022) 140 (Supplement 1): 12029–12030.

https://doi.org/10.1182/blood-2022-160045

Published: 2022

Journal Articles

Fatalities from Tumor Lysis Syndrome (TLS) after Anti-Hyperuricemic Monotherapy - Nationally Representative, Propensity Score Matched, Retrospective Study Comparison of Rasburicase and Allopurinol

Mitchell S Cairo, Jack R Gallagher, Yvonne Barnes, Edward Drea, Susan Carroll

Blood (2022) 140 (Supplement 1): 8136.

https://doi.org/10.1182/blood-2022-169864

Published: 2022

Journal Articles

A Phase II Study to Evaluate the Safety and Efficacy of Defibrotide in Sickle Cell Disease-Related Acute Chest Syndrome (IND 127812)

Edo Schaefer, Temima Kanarfogel, Jessica C Hochberg, Emily Thatcher, Liana Klejmont, Yaya Chu, Qiuhu Shi, Allen J Dozor, Deborah Friedman, Harshini Mahanti, Erin Morris, Sandra Fabricatore, John DeFresne, Kenneth R. Cooke, Mitchell S Cairo

Blood (2022) 140 (Supplement 1): 2532–2534.

https://doi.org/10.1182/blood-2022-168299

Published: 2022

Journal Articles

Final Results of Phase I/II Trial of Mitoxantrone in Combination with Clofarabine (MITCL) in Children with Relapsed/Refractory Acute Leukemia

Jessica C Hochberg, Javier Oesterheld, Aliza Gardenswartz, Liana Klejmont, Jaclyn Basso, Elizabeth Mintzer, Lauren Harrison, Michael J Borowitz, Michael R. Loken, Mitchell S Cairo

Blood (2022) 140 (Supplement 1): 6140–6141.

https://doi.org/10.1182/blood-2022-167040

Published: 2022

Journal Articles

Evaluation of Unrestricted Somatic Stem Cells Therapy in an Ex-Vivo and in-Vivo Acquired Severe Aplastic Anemia Model

Edo Schaefer, Yanling Liao, Morgan Anderson-Crannage, Bruno Hochberg, Hanif Mouehla, Jian Pan, Bernadette Fallon, Janet Ayello, Mitchell S. Cairo

Blood (2022) 140 (Supplement 1): 8641–8642.

https://doi.org/10.1182/blood-2022-162820

Published: 2022

Journal Articles

Survival of Patients with Extranodal NK-Cell Lymphoma in the United States

Ana C. Xavier, Nader Kim El-Mallawany, Matt J. Ehrhardt, Luciano J. Costa, Mitchell S. Cairo

Blood (2022) 140 (Supplement 1): 6563–6564.

https://doi.org/10.1182/blood-2022-160023

Published: 2022

Journal Articles

Phase 1b Trial of Subcutaneous Epcoritamab in Pediatric Patients with Relapsed or Refractory (R/R) Aggressive Mature B-Cell Neoplasms (EPCORE Peds-1)

Mitchell S. Cairo, Mark A. Rocco, John Bernard, Satya R. Siddani, Apurvasena Parikh, Brian Elliott, Birgit Burkhardt

Blood (2022) 140 (Supplement 1): 3827–3828.

https://doi.org/10.1182/blood-2022-157546

Published: 2022

Journal Articles

Safety, Tolerability, PK/PD and Preliminary Efficacy of NKTR-255, a Novel IL-15 Receptor Agonist, in Patients with Relapsed/Refractory Hematologic Malignancies

Blood (2021) 138 (Supplement 1): 3134.

https://doi.org/10.1182/blood-2021-147758

Published: 2021

Journal Articles

The Safety and Efficacy of Granulocyte Transfusions in Pediatric Recipients with Severe Neutropenia

Elysia R. Cohen, Madeline Miceli, Jibran Ahmed, Alexandra Jimenez, Bruce Sachais, Delong Liu, Mitchell S. Cairo, Jeremy Rosenblum

Blood (2021) 138 (Supplement 1): 2148.

https://doi.org/10.1182/blood-2021-151259

Published: 2021

Journal Articles

Manufacture and Immunological Characterization of GMP-Compliant Functional Sars-COV-2 Cytotoxic T Lymphocytes (CTLs) Utilizing the Clinimacs ® Cytokine Capture System

Blood (2021) 138 (Supplement 1): 476.

https://doi.org/10.1182/blood-2021-145620

Published: 2021

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Defibrotide Reduces Hypercoagulable State in Patients with Sickle Cell Disease-Related Acute Chest Syndrome (IND 127812)

Fertility and Sexual Development Outcomes in Pubertal and Post-Pubertal Children and Young Adults after Myeloablative Conditioning (MAC) and Familial Haploidentical T-Cell Depleted Allogeneic Stem Cell Transplantation

A Phase II Study to Evaluate the Safety and Efficacy of Defibrotide and Changes in Plasma Biomarkers in Sickle Cell Disease-Related Acute Chest Syndrome (IND 127812)

A Phase II Study to Evaluate the Safety and Efficacy of Defibrotide in Children with High Risk Kawasaki Disease (IND 127812)

Optimizing Ex-Vivo Expanded NK Cell- Mediated Cellular Cytotoxicity By Obinutuzumab Combined with NKTR-255 in Burkitt Lymphoma (BL)

Multicenter Pilot Trial of Intrathecal Liposomal Cytarabine Combined with FAB Chemoimmunotherapy with Reduced Doxorubicin in CAYA with Mature De-Novo B-NHL

Targeted Immunotherapy and Checkpoint Blockade in Children, Adolescents, and Young Adults with Lymphoma: Radical Hodgkin Cohort

Treatment of Refractory Adenovirus (ADV) Infections Using Adv-Specific Cytotoxic T-Lymphocytes (CTLs) in Children, Adolescents and Young Adults (CAYA) Post Allogeneic Hematopoietic Stem Cell Transplantation (AlloHSCT), Solid Organ Transplantation (SOT), or with Primary Immunodeficiency (PID)

EBV: the virus that keeps on giving!

KIR-favorable TCR-αβ/CD19-depleted haploidentical HCT in children with ALL/AML/MDS: primary analysis of the PTCTC ONC1401 trial

Pilot Study Using Induction Chemo-Immunotherapy Followed By Consolidation with Reduced Toxicity Conditioning and Allogeneic Stem Cell Transplant in Advanced Stage Mature Non-Anaplastic T- or NK-Cell Lymphoma/Leukemia in Children, Adolescent, and Young Adults

Fatalities from Tumor Lysis Syndrome (TLS) after Anti-Hyperuricemic Monotherapy - Nationally Representative, Propensity Score Matched, Retrospective Study Comparison of Rasburicase and Allopurinol

A Phase II Study to Evaluate the Safety and Efficacy of Defibrotide in Sickle Cell Disease-Related Acute Chest Syndrome (IND 127812)

Final Results of Phase I/II Trial of Mitoxantrone in Combination with Clofarabine (MITCL) in Children with Relapsed/Refractory Acute Leukemia

Evaluation of Unrestricted Somatic Stem Cells Therapy in an Ex-Vivo and in-Vivo Acquired Severe Aplastic Anemia Model

Survival of Patients with Extranodal NK-Cell Lymphoma in the United States

Phase 1b Trial of Subcutaneous Epcoritamab in Pediatric Patients with Relapsed or Refractory (R/R) Aggressive Mature B-Cell Neoplasms (EPCORE Peds-1)

Safety, Tolerability, PK/PD and Preliminary Efficacy of NKTR-255, a Novel IL-15 Receptor Agonist, in Patients with Relapsed/Refractory Hematologic Malignancies

The Safety and Efficacy of Granulocyte Transfusions in Pediatric Recipients with Severe Neutropenia

Manufacture and Immunological Characterization of GMP-Compliant Functional Sars-COV-2 Cytotoxic T Lymphocytes (CTLs) Utilizing the Clinimacs ® Cytokine Capture System

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only